Kucers' the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs
 |
Autor: M. Lindsay Grayson,Suzanne Crowe,James McCarthy,John Mills,Johan Mouton,Ragnar Norrby,David Paterson,Michael Pfaller ISBN: 9780340927670 Anul: 2011 Ediţia: 6 Pagini: 3000 Preţ (cu tva): 2725,00 lei 2180,00 lei Oferta este valabilă până la 31.03.2013
|
DESCRIERE I am unaware of any textbook which provides such comprehensive coverage of the field and doubt that this work will be surpassed in the foreseeable future, if ever!’ From the foreword by Robert C. Moellering, Jr., M.D, Shields Warren-Mallinckrodt Professor of Medical Research, Harvard Medical School, USA • Written by a top international editorial team • Extensively updated to include new, existing and emerging drugs • Divided into 4 sections, 258 chapters and presented in 2-volumes • Presented and packaged in 2-volumes plus an e-book Kucers’ The Use of Antibiotics is the leading major reference work in this vast and rapidly developing field. More than doubled in length compared to the fifth edition, the sixth edition comprises 3000 pages over 2-volumes in order to cover all new and existing therapies, and emerging drugs not yet fully licensed. Concentrating on the treatment of infectious diseases, the content is divided into 4 sections: antibiotics, anti-fungal drugs,anti-parasitic drugs and anti-viral drugs, and is highly structured for ease of reference.Within each section, each chapter is structured to cover susceptibility, formulations and dosing (adult and paediatric), pharmacokinetics and pharmacodynamics, toxicity and drug distribution, detailed discussion regarding clinical uses, a feature unique to this title. Compiled by an expanded team of internationally renowned and respected editors, with a vast number of contributors spanning Europe, Africa, Asia, Australia, South America, the US and Canada, the sixth edition adopts a truly global approach. It will remain invaluable for anyone using antimicrobial agents in their clinical practice and provides in a systematic and concise manner all the information required when treating infections requiring antimicrobial therapy. Now Kucers’ The Use of Antibiotics is available free to purchasers of the books as an electronic version on line or on your desktop: • It provides access to the entire 2-volume print material • It is fully searchable, so you can find the relevant information you need quickly • Live references are linked to PubMed referring you to the latest journal material • Customise the contents – you can highlight sections and make notes • Comments can be shared with colleagues/tutors for discussion, teaching and learning • The text can also be reflowed for ease of reading • Text and illustrations copied will be automatically referenced to Kucers’ The Use of Antibiotics * THE essential reference to this vast, and rapidly developing field * Highly structured for ease of reference * Covers more than 350 individal antimicrobial agents, more than twice as many as the preceding edition * International team of highly respected authors and editors ensures a truly global approach Table of Contents: ANTIBIOTICS PART 1 - Penicillins and Related Drugs Benzylpenicillin (Penicillin G) Phenoxypenicillins Ampicillin, Amoxicillin and other Ampicillin-like penicillins Methicillin Isoxazolyl penicillins: Oxacillin, cloxacillin, dicloxacillin & flucloxacillin Nafcillin Carbenicillin, Carindacillin, Carfecillin & Ticarcillin Mezlocillin, Azlocillin, Apalcillin & Piperacillin Mecillinam (Amdinocillin) & Pivmecillinam Temocillin Beta-lactamase inhibitors and combinations: Clavulanic Acid Sulbactam Tazobactam and Brobactam Co-amoxiclav (amoxycillin-clavulanic acid) Ampicillin-sulbactam Ticarcillin-clavulanic acid Piperacillin-tazobactam PART 2 - Cephalosporins and Related Drugs n=18 Cephalothin and Cefazolin Cephalexin Cephadroxil, Cephaloridine, Cephacetrile, Cephapirin, Cephradine and other rarely used first-generation cephalosporins Cefaclor, cefprozil and loracarbef Cefuroxime Cefotiam, Cefuzonam, Cefamandole, Cefonicid and Ceforanide Cefoxitin, cefotetan and other cephamycins (cefmetazole and flomoxef) Cefoperazone and cefoperazone-sulbactam Cefotaxime Ceftriaxone Ceftizoxime, cefdinir, cefditoren, cefpodoxime, ceftibuten, cefsulodin and cefpiramide Cefixime Ceftazidime Cefpirome Cefepime Ceftaroline Ceftobiprole Aztreonam PART 3 – Carbapenems n=9 Imipenem Meropenem Doripenem Ertapenem Biapenem Faropenem Panipenem Ritapenem Sulopenem PART 4 - Glycopeptides and Lipopeptides Vancomycin Teicoplanin Daptomycin Oritavancin Dalbavancin Telavancin Ramoplanin PART 5 - Aminoglycosides Kanamycin Gentamicin Tobramycin Amikacin Sisomicin and Netilmicin Isepamicin Neomycin PART 6 – Macrolides and Ketolides Erythromycin Roxithromycin Clarithromycin Azithromycin Josamycin and Rosaramicin Telithromycin Cethromycin PART 7 – Tetracyclines and related drugs Tetracycline Doxycycline Minocycline Tigecycline PART 8 – Other antibiotics Linezolid Quinupristin-dalfopristin Pristinamycin Fosfomycin Fusidic acid (Fusidate sodium) Polymyxins and Colistin Novobiocin Bacitracin and Gramicidin Mupirocin Clindamycin and Lincomycin Chloramphenicol and Thiamphenicol Spectinomycin PART 9 – Anti-folate agents and other synthetic antibacterials Sulfonamides Trimethoprim, Co-trimoxazole (Co-T) & related agents Pyrimethamine Dapsone Trimetrexate Iclaprim Nitrofurans: Nitrofurazone, Furazolidone & Nitrofurantoin Methenamine Mandelate & Methenamine Hippurate PART 10 – Nitroimidazoles Metronidazole Tinidazole PART 11 – Quinolones and fluoroquinolones Nalidixic Acid & Other Older Quinolones Ciprofloxacin Norfloxacin Ofloxacin Levofloxacin Moxifloxacin Gatifloxacin Garenoxacin Gemifloxacin Sitafloxacin Enoxacin Pefloxacin Sparfloxacin Lomefloxacin Rufloxacin Tosufloxacin Fleroxacin Newer, discontinued fluoroquinolones: Temafloxacin, Trovafloxacin, Grepafloxacin and Clinafloxacin PART 12 – Anti-Tuberculous Drugs Isoniazid Ethambutol Pyrazinamide Rifampicin (Rifampin) Rifabutin Rifaximin Rifapentine Streptomycin Para-aminosalicylic Acid (PAS) Ethionamide and prothionamide Thiacetazone Capreomycin Cycloserine Viomycin ANTI-FUNGAL DRUGS PART 1 - Polyenes Amphotericin B (AMB): Deoxycholate & Lipid Formulations Nystatin Natamycin (Pimaricin) PART 2 – Echinocandins, Allylamines and Benzylamine derivatives Echinocandins – Caspofungin, Anidulafungin & Micafungin Terbinafine Butenafine Naftifine PART 3 – Systemic Azoles Ketoconazole Fluconazole Itraconazole Miconazole Voriconazole Posaconazole Ravuconazole Albaconazole Isavuconazole PART 4 – Topical Azoles Bifonazole Butoconazole Clotrimazole Croconazole Eberconazole Econazole Enilconazole Fenticonazole Flutrimazole Isoconazole Lanoconazole Neticonazole Oxiconazole Sertaconazole Sulconazole Terconazole Tioconazole KP-103 PART 5 – Topical agents – Thiocarbamates, Hydroxypyridones and Morpholine Tolnaftate Amorolfine Ciclopirox Rilopirox PART 6 – Other antifungal agents and new agents in development Flucytosine (5-Fluorocytosine; 5-FC) Griseofulvin Haloprogin New agents in development – Nikkomycin Z, CAY-1, Sodarins, Butenolides, Enfungumab, Inositol phosphoceramide synthase inhibitors ANTI-PARASITIC DRUGS PART 1 – Anti-malarial agents Chloroquine Amodiaquine Quinine and quinidine Mefloquine Halofantrine Lumefantrine Primaquine Piperaquine Tafenoquine Atovaquone Proguanil & chloroproguanil Artemisinins PART 2 - Agents active against Intestinal and Intra-abdominal Protozoa Iodoquinol & Quinacrine Fumagillin Furazolidone (Furazolidine) Diloxanide furoate Spiramycin Nitazoxanide Paromomycin PART 3 - Agents active against American Trypanosomiasis Benznidazole Nifurtimox PART 4 - Agents active against African Trypanosomiasis Suramin Melarsoprol Eflornithine PART 5 – Agents active against leishmania and other pathogens Pentamidine Antimonial agents Miltefosine PART 6 - Agents active against Helminths Albendazole Mebendazole Thiabendazole Triclabendazole Ivermectin Diethylcarbamazine (DEC) Pyrantel pamoate Praziquantel Oxamniquine Metrifonate Niclosamide PART 7 - Agents active against Ectoparasites Permethrin Piperonyl butoxide Lindane Malathion Crotamiton ANTI-VIRAL DRUGS PART 1 - Agents active against Herpesviruses Aciclovir Valaciclovir Famciclovir & Penciclovir Ganciclovir & Valganciclovir Cidofovir Vidarabine Foscarnet Maribavir Trifluridine (Trifluorothymidine) Idoxuridine Fomivirsen PART 2 - Agents active against Human Immunodeficiency Virus 2a - Inhibitors of Reverse Transcriptase Zidovudine Didanosine Zalcitabine Lamivudine Stavudine (d4T) Abacavir Emtricitabine Tenofovir Amdoxovir Apricitabine 2b – Non-Nucleoside Reverse Transcriptase inhibitors (NNRTIs) Nevirapine Efavirenz Delavirdine Etravirine Rilpirivine 2c - Inhibitors of HIV Protease Saquinavir Ritonavir Indinavir Nelfinavir Lopinavir Amprenavir and fosamprenavir Darunavir Atazanavir Tipranavir 2d - Other Anti-HIV Agents Enfuvirtide Maraviroc Raltegravir & other HIV integrase inibitors Part 3 - Agents active against Hepatitis viruses Entecavir Adefovir dipivoxil Telbivudine Torcitabine & Valtorcitabine Clevudine Ribavirin & Viramidine Pegylated Interferon Alfa Protease and polymerase inhibitors for the treatment of hepatitis C virus infection Part 4 - Agents active against Respiratory viruses Amantadine & Rimantadine Zanamivir and Polymeric Zanamivir Conjugates Oseltamivir Peramivir OPINIA CITITORILOR
| Nu există opinii exprimate. Fii primul care comentează. |
 |
 Antibiotic Essentials 2012Burke A. Cunha, MD, Chief, Infectious Disease Division at Winthrop-University Hospital, Mineola, New York, Professor, State University of New York School of Medicine, Stony Brook, New York 109,00 lei |
 2012-2013 Nelson's Pediatric Antimicrobial TherapyJohn S. Bradley (editor) and John D. Nelson (editor) 185,30 lei |
 Meningitis: Causes, Diagnosis, and TreatmentGrigoris Houllis, Magdalini Karachalios 654,00 lei |
 Inflammatory Diseases of Blood VesselsGary S. Hoffman (Editor), Cornelia M. Weyand (Editor), Carol A. Langford (Editor), Jorg J. Goronzy (Editor) 817,50 lei |
 Atlas of Human Infectious DiseasesWertheim, Heiman F. L.; Horby, Peter; Woodall, John P. 436,00 lei |
 Schaechter's Mechanisms of Microbial DiseaseN. C Engleberg MD Terence Dermody PhD Victor DiRita PhD 272,50 lei |
|